O
SPPI

OppenheimerFunds’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

OppenheimerFunds’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-17,026
Closed -$127K – 1879
2017
Q2 		$127K Sell
17,026
-431
-2% -$2.82K ﹤0.01% 1842
2017
Q1 		$113K Sell
17,457
-4,747
-21% -$26.5K ﹤0.01% 1851
2016
Q4 		$98K Buy
22,204
+7,248
+48% +$30.4K ﹤0.01% 1776
2016
Q3 		$70K Buy
14,956
+3,538
+31% +$21K ﹤0.01% 1716
2016
Q2 		$75K Sell
11,418
-841
-7% -$5.94K ﹤0.01% 1682
2016
Q1 		$78K Sell
12,259
-1,968
-14% -$10.1K ﹤0.01% 1669
2015
Q4 		$86K Buy
+14,227
New +$81.4K ﹤0.01% 1724

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OppenheimerFunds's SPPI Position: Q3 2017 in Review

OppenheimerFunds sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2017, closing a stake of 17,026 shares — an estimated $127K sold.

OppenheimerFunds first reported a position in SPPI in Q4 2015 and held it in 7 quarters. The position peaked at $127K in Q2 2017. 158 funds tracked by Wall St. Rank hold SPPI as of Q3 2017.

  • OppenheimerFunds reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
  • OppenheimerFunds sold 17,026 Spectrum Pharmaceuticals Inc shares in Q3 2017, an estimated $127K.
  • OppenheimerFunds first reported a position in Spectrum Pharmaceuticals Inc in Q4 2015 and held it in 7 quarters.
  • OppenheimerFunds's Spectrum Pharmaceuticals Inc position peaked at $127K in Q2 2017.
  • 158 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2017.

Based on OppenheimerFunds's 13F filing for Q3 2017, filed 13 Nov 2017.